NELBIE ANNE DURAN: Open Payments
NPI 1841874567 · SPOKANE VALLEY, WA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,402 in 89 payments from 34 companies in 2025. Trend: 2023 $839 · 2024 $1,584 · 2025 $2,402
Food & beverage: $2,402
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 21 | $293 |
| AstraZeneca Pharmaceuticals LP | 11 | $293 |
| Regeneron Healthcare Solutions, Inc. | 3 | $194 |
| ABBVIE INC. | 6 | $175 |
| GENZYME CORPORATION | 3 | $175 |
| Geron Corporation | 1 | $123 |
| Genmab U.S., Inc. | 1 | $104 |
| Janssen Biotech, Inc. | 4 | $97 |
| PFIZER INC. | 4 | $94 |
| GlaxoSmithKline, LLC. | 4 | $74 |
Products named: LYNOZYFIC, IMFINZI, EPKINLY, SARCLISA, RYTELO, SCEMBLIX, Fabhalta, KISQALI.
Industry payments across WA — which companies pay providers there.
